- Press Release Distribution

Ingestible vital signs monitor shows promise in first-in-human trial

New device developed by a company founded by Brigham researchers detected an opioid-overdose in preclinical models and captured respiratory rates and heart rates in 10 patients with sleep apnea

Ingestible vital signs monitor shows promise in first-in-human trial
( What if, instead of going into a sleep lab or being connected to monitoring devices, a patient could have their risk of obstructive sleep apnea measured by swallowing a pill? A new collaborative study from Brigham and Women’s Hospital, a founding member of the Mass General Brigham healthcare system, Massachusetts Institute of Technology, Celero Systems and West Virginia University, evaluated a wireless ingestible device that can accurately report vital signs like heart and respiratory rate. The team tested the device, known as the Vitals Monitoring Pill (VM Pill), in a pilot clinical study of 10 people with sleep apnea. It was also able to detect signs of opioid-induced respiratory depression in a preclinical model. Their results, published in Device, could transform how life-threatening events are monitored and prevented.

 “We have developed an ingestible electronic capsule that detects different movements associated with specific vital signs,” said co-corresponding author Giovanni Traverso, MB, BChir, PhD, a gastroenterologist in the Brigham’s Division of Gastroenterology, Hepatology, and Endoscopy. Traverso is also an associate professor of mechanical engineering at MIT. “We anticipate that there will be broad applications for this device, with the potential to improve monitoring for sleep apnea and other breathing conditions.”

The development of wearable and portable monitoring devices can help promote survival through early detection and intervention. Similarly, patients with sleep apnea can also benefit from non-intrusive tracking of vitals. Obstructive sleep apnea, a condition in which the upper airway becomes partially or fully blocked when asleep, affects millions of adults in the United States. Evaluating sleep apnea usually involves connections to complicated monitoring devices that can be burdensome to the patient.

Additionally, the opioid epidemic has led to a dramatic rise in overdoses, fatal episodes of slow and shallow breathing, or respiratory depression. More than half of these overdoses occur when the individual is alone and outside medical facilities, where caregivers and healthcare providers cannot monitor signs of respiratory distress. Existing vital sign monitors are bulky and difficult to use without supervision.

Traverso and his collaborators first demonstrated accurate vital sign measurements by the VM Pill in a preclinical model. Information from the device was relayed to a receiver attached via USB interface to a laptop. They then collected 57 hours of data from ten subjects at the West Virginia University (WVU) Medicine Sleep Evaluation Center for the first-in-human pilot clinical study of the VM Pill.

They found that respiratory and heart rate data captured by the VM Pill was comparable to data from existing monitoring devices. Analysis of the data showed respiratory rhythms within the expected range of 9 to 25 breaths per minute, and cardiac signals within the range of 40 to 95 beats per minute.

The device was also able to capture moments when subjects stopped breathing, either by intentionally holding their breath, or during sleep apnea events. Interference from external sleep apnea monitoring devices did not affect signals from the VM Pill. Radiograph imaging after the study confirmed the excretion of the device without incident in all subjects.

In addition, the researchers also tested the device in a preclinical model of fentanyl overdose. The capsule was able to detect respiratory depression caused within a minute of overdose in real-time.

The authors note that their sleep apnea evaluation was limited to subjects who were sleeping or at rest in bed and further evaluation is needed to measure vital signs in a more natural use environment. The animal overdose model was also limited in that the animals were already anesthetized before opioids were administered.

Future work could test the device’s monitoring capabilities during gastrointestinal procedures lasting up to a week, unobtrusive detection of overdoses and interventions for diagnosis of sleep apnea.

“Our study provides a tangible product with real commercial value,” said Traverso, Associate Professor in the Department of Mechanical Engineering at the Massachusetts Institute of Technology. “Ingestible vital monitors can really transform our capacity to rapidly respond to life-threatening events.”

Celero Systems was founded in 2017 to develop and commercialize ingestible electronic devices like the VM Pill.  Traverso is a founder and member of the board of directors for the company, which has licensed intellectual property related to the VM Pill from Mass General Brigham.

 As a world-recognized leader in research and innovation, discoveries at Mass General Brigham have led to the creation of hundreds of new companies that have spurred scientific innovation and economic growth across Massachusetts, nation, and globe. These companies enable patients around the world to benefit from Mass General Brigham discoveries.

Authorship: Additional authors include Victor Finomore, Jr, James Mahoney III, Justin Kupec, Robert Stansbury, Daniel Bacher, Benjamin Pless, Shannon Schuetz, Alison Hayward, Robert Langer, Ali Rezai.

Disclosures: Bacher, Schuetz, and Pless are employees of Celero Systems, Inc. Langer, Hayward and Traverso have a financial interest in Celero Systems, Inc.  Rezai is an advisor to Celero Systems, Inc.  Bacher and Pless are co-inventors on published patent applications (US20210060317, EP4021271) encompassing the work described. Pless and Traverso are founders and members of the Board of Directors of Celero Systems, Inc. 

Paper cited: Traverso, Giovanni et al. “First-in-human trial of an ingestible vitals monitoring pill” Device DOI: 10.1016/j.device.2023.100125




[Attachments] See images for this press release:
Ingestible vital signs monitor shows promise in first-in-human trial


Putting an end to plastic separation anxiety

Putting an end to plastic separation anxiety
Bio-based plastics such as polylactic acid (PLA) were invented to help solve the plastic waste crisis, but they often end up making waste management more challenging. Because these materials look and feel so similar to conventional, petroleum-based plastics, many products end up not in composters, where they break down as designed, but instead get added to the recycling stream by well-intentioned consumers. There, the products get shredded and melted down with the recyclable plastics, bringing down the quality of the mixture and making it harder to manufacture functional products out of recycled plastic resin. The only solution, currently, is to try to separate the different ...

Ingestible electronic device detects breathing depression in patients

Ingestible electronic device detects breathing depression in patients
CAMBRIDGE, MA -- Diagnosing sleep disorders such as sleep apnea usually requires a patient to spend the night in a sleep lab, hooked up to a variety of sensors and monitors. Researchers from MIT, Celero Systems, and West Virginia University hope to make that process less intrusive, using an ingestible capsule they developed that can monitor vital signs from within the patient’s GI tract. The capsule, which is about the size of a multivitamin, uses an accelerometer to measure the patient’s breathing rate and heart rate. In addition to diagnosing sleep apnea, the device could also be useful for detecting ...

Higher-dose fluvoxamine and time to sustained recovery in outpatients with COVID-19

About The Study: Among outpatient adults with mild to moderate COVID-19, treatment with fluvoxamine 100 mg twice daily for 13 days, compared with placebo, did not improve time to sustained recovery in this randomized clinical trial of 1,175 participants.  Authors: Susanna Naggie, M.D., M.H.S., of the Duke University School of Medicine in Durham, North Carolina, is the corresponding author. To access the embargoed study: Visit our For The Media website at this link (doi:10.1001/jama.2023.23363) Editor’s Note: Please see the article for additional information, ...

Educational outcomes for children at 7 to 9 years of age after birth at 39 vs 40 to 42 weeks’ gestation

About The Study: In this study of 155,000 births, using a causal inference framework based on target trial emulation, birth at 39 weeks’ gestation was not associated with adverse numeracy and literacy outcomes at school age compared with birth at 40 to 42 weeks.  Authors: Roxanne Hastie, Ph.D., of the University of Melbourne, is the corresponding author.  To access the embargoed study: Visit our For The Media website at this link  (doi:10.1001/jamanetworkopen.2023.43721) Editor’s Note: Please see the article for ...

State reporting requirements for involuntary holds, court-ordered guardianship, and the national firearm background check system

About The Study: In this study of state laws, there was substantial heterogeneity in National Instant Criminal Background Check System (NICS) reporting requirements for mental health prohibitions for firearm possession and a lack of clarity around processes. This raises questions about the ability of NICS to be used to block firearm purchases or possession by individuals with court-identified high risk of perpetrating violence toward themselves or others.  Authors: Marian E. Betz, M.D., M.P.H., of the University of Colorado Anschutz Medical Campus School of Medicine in Aurora, is the ...

Benefits of adolescent fitness to future cardiovascular health possibly overestimated

There is a well-known relationship between good physical fitness at a young age and a lower risk of cardiovascular disease later in life. However, when researchers adjusted for familial factors by means of sibling analysis, they found a weaker association, although the link between high body mass index (BMI) and cardiovascular disease remained strong. The study, which was conducted by researchers from Karolinska Institutet and other universities, is published in JAMA Network Open. “This does not mean that fitness is irrelevant,” ...

Following a Mediterranean diet reduces the risk of cognitive decline in older people

Old people who follow a Mediterranean diet are at a lower risk of cognitive decline, according to a study published in the journal Molecular Nutrition and Food Research. The study provides new evidence for a better understanding of the biological mechanisms related to the impact of the diet on cognitive health in the ageing population. The study is led by Mireia Urpí-Sardá, adjunct lecturer and member of the Biomarkers and Nutritional & Food Metabolomics research group of the Faculty of Pharmacy and Food Sciences, the Institute for Nutrition and Food Safety (INSA-UB), the Food and Nutrition Torribera Campus of the University of Barcelona, and the CIBER on Frailty and ...

A deep-sea fish inspired researchers to develop supramolecular light-driven machinery

A deep-sea fish inspired researchers to develop supramolecular light-driven machinery
The vision system, evolved over millions of years, is highly complex. To make vision sensitive throughout the whole range of visible wavelengths, Nature employs a supramolecular chemistry approach. The visual pigment, cis-retinal, changes its shape upon capturing a photon. This shape transformation is accompanied by changes in the supramolecular organization of the surrounding proteins, subsequently triggering a cascade of chemical signaling events that get amplified and eventually lead to visual perception in the brain. “Some deep-sea fish have evolved antenna-like ...

Shedding light on unique conduction mechanisms in a new type of perovskite oxide

Shedding light on unique conduction mechanisms in a new type of perovskite oxide
The remarkable proton and oxide-ion (dual-ion) conductivities of hexagonal perovskite-related oxide Ba7Nb3.8Mo1.2O20.1 are promising for next-generation electrochemical devices, as reported by scientists at Tokyo Tech. The unique ion-transport mechanisms they unveiled will hopefully pave the way for better dual-ion conductors, which could play an essential role in tomorrow’s clean energy technologies. Clean energy technologies are the cornerstone of sustainable societies, and solid-oxide fuel cells (SOFCs) and proton ceramic fuel cells (PCFCs) are among the most promising types of electrochemical devices for green power generation. These devices, however, still ...

UK’s Rural Physician Leadership Program, Anthem Medicaid announce new rural medicine scholarships

UK’s Rural Physician Leadership Program, Anthem Medicaid announce new rural medicine scholarships
MOREHEAD, Ky. (Nov. 17, 2023) — In celebration of National Rural Health Day, yesterday the University of Kentucky College of Medicine and Anthem Blue Cross and Blue Shield Medicaid in Kentucky announced new scholarship opportunities for UK’s Rural Physician Leadership Program (RPLP). The Anthem Rural Medicine Scholarships will provide $100,000 to offset the cost of medical school for students in the RPLP. In a state that suffers from high rates for many chronic, ...


Tanzanian officials praise NEST360 contribution to newborn care

4D Medicine raises £3.4 million for unique biomaterial platform

Ancient marine animal had inventive past despite being represented by few species, new study finds

Quantum sensor for the atomic world developed through international scientific collaboration

The research was wrong: study shows moderate drinking won’t lengthen your life

Save your data on printable magnetic devices? New laser technique’s twist might make this reality

Early onset dementia more common than previously reported – the incidence of Alzheimer’s disease seems to be on the rise

Pesticides potentially as bad as smoking for increased risk in certain cancers

NUS researchers develop new battery-free technology to power electronic devices using ambient radiofrequency signals

New protein discovery may influence future cancer treatment

Timing matters: Scripps Research study shows ways to improve health alerts

New gene therapy approach shows promise for Duchenne muscular dystrophy

Chemical analyses find hidden elements from renaissance astronomer Tycho Brahe’s alchemy laboratory

Pacific Northwest launches clean hydrogen energy hub

Tiny deletion in heart muscle protein briefly affects embryonic ventricles but has long-term effects on adult atrial fibrillation

Harms of prescribing NSAIDs to high risk groups estimated to cost NHS £31m over 10 years

Wearing a face mask in public spaces cuts risk of common respiratory symptoms, suggests Norway study

Some private biobanks overinflating the value of umbilical cord blood banking in marketing to expectant parents

New research in fatty liver disease aims to help with early intervention

Genetics reveal ancient trade routes and path to domestication of the Four Corners potato

SNIS 2024: New study shows critical improvements in treating rare eye cancer in children

Wearable devices can increase health anxiety. Could they adversely affect health?

Addressing wounds of war

Rice researchers develop innovative battery recycling method

It’s got praying mantis eyes

Stroke recovery: It’s in the genes

Foam fluidics showcase Rice lab’s creative approach to circuit design

Montana State scientists publish evidence for new groups of methane-producing organisms

Daily rhythms depend on receptor density in biological clock

New England Journal of Medicine publishes outcomes from practice-changing E1910 trial for patients with BCR::ABL1-negative B-cell precursor acute lymphoblastic leukemia

[] Ingestible vital signs monitor shows promise in first-in-human trial
New device developed by a company founded by Brigham researchers detected an opioid-overdose in preclinical models and captured respiratory rates and heart rates in 10 patients with sleep apnea